FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 4003302 · Received August 12, 2014

Report

Report Number
2134265-2014-04611
Event Type
Injury
Date Received
August 12, 2014
Date of Event
April 4, 2011
Report Date
July 14, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

SAME CASE AS MFR: 2134265-2014-04613. (B)(4). IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED STENT THROMBOSIS AND SUBSEQUENT MYOCARDIAL INFARCTION. IN (B)(6) 2011, THE PATIENT PRESENTED WITH UNSTABLE ANGINA, BRAUNWALD CLASSIFICATION- IIIB, WHICH WAS DIAGNOSED AS A MYOCARDIAL INFARCTION (MI). CORONARY ANGIOGRAPHY REVEALED STENT THROMBOSIS OF AN UNSPECIFIED BSC STENT IN THE OSTIAL LEFT ANTERIOR DESCENDING (LAD) ARTERY AND A TOTAL OCCLUSION OF AN UNSPECIFIED BSC STENT IN THE MID LAD. TARGET LESION #1 WAS A BIFURCATED, TOTAL OCCLUSION LOCATED WITHIN THE BSC STENT IN THE MID LAD. THE LESION WAS 12MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.5MM. THIS LESION WAS TREATED WITH THROMBOSUCTION, PRE-DILATATION AND PLACEMENT OF A 2.50 MM X 16 MM PROMUS ELEMENT STENT. FOLLOWING POST DILATATION, RESIDUAL STENOSIS WAS 0%. TARGET LESION #2 WAS A TOTAL OCCLUSION LOCATED WITHIN THE BSC STENT IN THE PROXIMAL LAD. THE LESION WAS 20MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.0MM. THIS LESION WAS TREATED WITH PRE-DILATATION AND PLACEMENT OF A 3.00 MM X 20 MM PROMUS ELEMENT STENT. FOLLOWING POST DILATATION, RESIDUAL STENOSIS WAS 10%. THREE DAYS POST PROCEDURE THE PATIENT WAS DISCHARGED ON ASPIRIN AND CLOPIDOGREL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
479820 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY UNK433

Patients

Seq Age Sex Outcome Treatment
1 84 YR Required Intervention